Why testing anti-aging actives on static 3D skin models limits innovation: The mechanobiology advantage
In the cosmetic and dermocosmetic industries, 3D reconstructed skin models have long replaced traditional animal testing, establishing a gold standard for safety and efficacy evaluations. However, as highlighted in market analyses by consulting firm Alcimed (“Organoids for drug development: 3 strategic considerations for your preclinical pipeline”, 2026), the next frontier for 3D skin models lies